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Malassezia yeasts produce bioactive indolic substances when grown on L-
tryptophan agar. A panel of these substances was tested against commensal and 
opportunistic fungi, the Minimum Inhibitory Concentration (MIC) was determined 
and the potential for in loco antifungal activity on the skin was assessed.  
Materials and Methods 
Eight indoles were included (malassezin, pityriacitrin, indirubin, 
indolo[3,2b]carbazole, formyl-indolo[3,2 b]carbazole, tryptanthrin, 6-
hydroxymethyl-indolo[3,2-b]carbazole and 6-methyl-indolo[3,2-b]carbazole) and 
were tested against 40 fungal strains [yeasts: Malassezia spp.(N=9); Cryptococcus 
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(N=2); molds: Aspergillus spp.(N=7); Fusarium spp.(N=2); Rhizopus oryzae(N=2)]. 
The concentration of 5/8 of the tested indoles on diseased skin was calculated from 
published data. Kruskal-Wallis and U-Mann-Whitney tests were employed for group 
susceptibility evaluation in 33 strains.  
Results 
The MIC range was 0.125-32たg/ml and the median log2MIC was 4. Indirubin was 
the most potent antifungal agent and differed significantly from the others. The 
highest median MIC  was found for FICZ.  
Malassezia with Candida strains were more susceptible compared to Cryptococcus 
and Aspergillus and this inhibitory activity was predicted to be valid also on human 
skin.   
Conclusions 
Malassezia yeasts produce indolic species that inhibit an array of clinically 
significant yeasts and molds. 
 
Introduction 
The human skin harbors an array of microbial species and microorganisms with 
Malassezia yeasts being the principal eukaryotic organisms.1,2 This genus currently 
includes 17 species 3 and in humans has been associated with the development of 
pityriasis versicolor (PV), dandruff (DF)/seborrheic dermatits (SD) and certain head 
and neck manifestations of atopic dermatitis.4 All these common skin conditions are 
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Initially it was reported that M. furfur strains have the ability to produce indolic 
substances when grown in a medium with L-tryptophan as the exclusive nitrogen 
source.7 Subsequently, it was found that under the aforementioned culture conditions 
M. furfur strains isolated from SD and PV lesions have the ability to synthesize in 
vitro significantly larger quantities of indoles compared to those isolated from 
healthy skin.8 Furthermore, it has become clear that this property is not restricted to 
M. furfur but is wider distributed among more species within the genus, while 
Malassezia and their respective indoles can be also traced in skin scales from SD 
and PV patients.9 Important molecules of this group include malassezin, indirubin, 
indolo-[3,2b]-carbazole (ICZ), pityriacitrin 10 and formyl-indolo–[3,2b]-carbazole 
(FICZ). Among potential biological effects of these substances preliminary data 
indicate that indirubin possesses some antifungal11 and antiparasitic12 activity, whilst 
it could also potentiate the antibacterial effect of ciprofloxacin against resistant S. 
aureus strains in vitro.13 Moreover, pityriacitrin has a small, yet measurable, sunlight 
protective factor (SPF: 1.7) at 5% concentration14 and FICZ is considered a 
candidate endogenous aryl-hydrocarbon receptor (AhR) ligand and an ultraviolet 
damage mediator on human skin.15 Regarding indirubin it mediates functions as 
inflammation and tumorigenesis16 and is currently suggested as a potent topical 
treatment for psoriasis.17 The production of these ligands from L-tryptophan is not 
restricted to yeasts of the Malassezia genus but has also been described in the 
ascomycetous gastrointestinal truck commensal C. glabrata underscoring the wider 
biological significance of this pathway.18 
Aim of this study was to screen indoles detectable in Malassezia cultures for 
determining antifungal activity against a selection of commensal and opportunistic 
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to the concentrations of the respective indoles in skin scales in order to predict 
potential in loco antifungal activity of Malassezia related indoles.  
Materials and Methods 
Forty fungal strains maintained at the Hellenic Collection of Pathogenic Fungi-
UOA/HCPF were tested against 8 Malassezia indoles (Table 1) including the 5 
indoles previously isolated from diseased skin (malassezin, pityriacitrin, ICZ, 
indirubin, FICZ) and 3 additional ones tryptanthrin, 6-hydroxymethyl-indolo [3,2-b] 
carbazole (H) and 6-methyl-indolo [3,2-b] carbazole (M)  (Table 2). The tested 
strains included 27 yeasts comprising Malassezia spp. (N=9); Cryptococcus spp. 
(N=10); Candida spp. (N=7); Yarrowia lipolytica (N=1); the black yeast Exophialla 
dermatitidis (N=2); and 13 molds Aspergillus spp. (N=7); Fusarium spp. (N=2); 
Rhizopus oryzae (N=2). The used indoles were synthesized as previously8,9,10 and 
were maintained in 10-2M dimethyl sulfoxide stock solutions. For the broth 
microdilution method the CLSI M27-A3 and M38-A2 guidelines for yeasts and 
molds respectively were followed. Each strain was tested twice and on each testing 
occasion the quality control and reference strains respectively (Candida parapsilosis 
ATCC90018 and Candida albicans ATCC90028 for yeasts, and for molds the 
quality control and reference strains respectively Paecilomyces variotii ATCC 
MYA-3630 and Aspergillus fumigatus ATCC MYA-3626) were included. If the 
results for the quality control strains differed >2 dilutions the experiment was 
discarded. Regarding the results from the tested fungal strains, the higher MIC of the 
2 experiments is recorded in Table 1. This was performed in order to compensate for 
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The concentration of the applied indoles on human skin was calculated from data 
published previously.9 As the skin extracts mostly consist of skin lipids the density 
was taken at 0.9 gr/ml. For the transformation of the concentration of indoles in the 
skin extracts to corresponding たg/ml the following formula was employed:  
Cx (mol/mg extract) * Molecular weight * 109/ 0.9 (g/ml extract)= Cx (たg/ml) 
Statistical analysis 
In the statistical analysis the results from 33 strains were included as the yeast Y. 
lipolytica and the molds Rhizopus, Fusarium and Exophiala were excluded due to 
the small number of strains tested.  The group susceptibility of each of the indoles 
was evaluated with the Kruskal-Wallis and U Mann-Whitney tests employing the 
SPSS software (v22, Chicago, IL, USA 
Results 
Table 1 compiles the MIC values for the strains of the fungal species tested. Over all 
tested yeast strains and indolic substances median log2MIC was 4 (Fig. 1). Based on 
the presently employed array of fungal strains, from the indolic substances tested, 
indirubin (median log2 MIC=3) was the most potent antifungal agent and the only 
one that differed significantly in activity from any of the other ones: 6-methyl-indolo 
[3,2-b] carbazole (p=.015), malassezin (p=.004), pityriacitrin (p=.003), 6-
hydroxymethyl-indolo [3,2-b] carbazole (p=.003) and FICZ (p<.001). On the other 
hand the highest median MIC (log2MIC=5) was found for FICZ (Fig. 1).  
Regarding susceptibility by fungal genera two groups were discerned: Malassezia 
with Candida and Cryptococcus with Aspergillus. The former group was 













This article is protected by copyright. All rights reserved. 
(Figure 1; Panels A, C). The pattern of susceptibility was equivalent for each genus 
for pityriacitrin, FICZ and 6-hydroxymethyl-indolo [3,2-b] carbazole (Figure 1).  
The concentration of the Malassezia associated indoles isolated from lesional skin 
scales were transformed to たg/ml (Table 2) in order to compare the above 
susceptibility data to possible antifungal activity on the corresponding skin surface. 
From the 9 skin scales extracts 3 (2SD; 1PV) contain indole concentrations that 
would inhibit all fungal strains, including the Malassezia strains tested in this study. 
In two cases (SD2 and PV2) the respective inhibitory activity could be attributed to 
the indirubin concentration and in one to pityriactrin (SD3).  
Discussion 
Herein we demonstrate that indolic molecular species isolated from Malassezia 
cultures have antifungal activity in vitro at concentrations detected in scale probes 
selected form lesional SD and PV skin. From the indolic substances tested, indirubin 
is significantly the most active one. This molecule is the target of intense 
investigation as it possesses anti-inflammatory and anticancer properties and it is the 
active ingredient of indigo naturalis, a popular Chinese traditional medicine.16 As 
already mentioned it is evaluated as a topical agent in the treatment of psoriasis17 
and the antifungal properties detected herein could be an additional indication. 
Furthermore, low water solubility that characterizes indirubin could be an asset on 
the skin as it would not be easily removed from sweat. Strict, numerical comparison 
of the MIC with established antifungals19 of indirubin or the other indoles should not 
be performed as the antifungal function would be performed in loco on the skin and 
not after systemic intake in blood or tissue level. Thus, within the context that they 
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active in vivo against commensal (Malassezia and Candida), opportunistic 
pathogenic yeasts (Cryptococcus) and molds (Aspergillus). Furthermore, the 
existence of a synergistic action that adds to this effect cannot be excluded. 
A notable observation is that they show antifungal activity against their own 
producers, i.e. Malassezia and Candida species. The indole concentration achieved 
in vitro by Malassezia species when grown on L-tryptophan agar are 2-3 dilutions 
lower than the herein recorded MIC.8 This means that production of indoles in vitro 
does not inhibit Malassezia growth up to a point, yet the toxicity of these substances 
might explain the preferentially use of other nitrogen sources as is glycine and 
resolution to L-tryptophan use when these sources have been exhausted.20 As for 
Candida species, only C. glabrata has been found to produce indolic substances and 
from these, only tryptanthrin (Mexia and Magiatis unpublished data).  
Another issue underscored by the findings of this study is the exact role of 
Malassezia in the accumulation of indolic compounds in association with yeast 
colonies in vivo and in vitro.9  Most probably, on the skin the production of indolic 
compounds represents an adaptive phenomenon of certain Malassezia stains that can 
exploit their physico-chemical milieu in order to improve their survival competence 
by optimizing the bioenergetics of the assembly and accumulation of bioproducts in 
their environment. It has been proposed that the formation of these substances 
begins with an enzyme-mediated formation of indolepyruvate from L-tryptophan 
and the subsequent ‘avital’ transformation of the precursor substance into a whole 
array of further indolic compounds.21 Accordingly, malassezin can easily transform 
to ICZ22 and additional tryptophan metabolites can be formed on the skin through 
the action of the omnipresent UV radiation or further oxidative reactions.23 Taken all 
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controls the variation in the capacity of different Malassezia strains to accumulate 
indolic compounds in their environment is their ability to uptake and metabolize 
available L-tryptophan into indolepyruvate and to excrete it into the environment 
where subsequent formation of further molecular species continues depending on the 
available milieu conditions. Hence, effective antifungal concentrations of these 
substances might not be spatially related to the Malassezia microcolonies on the 
skin, thus not actually inhibiting the producer strains. 
In conclusion, Malassezia yeasts produce indolic species that have the ability to 
inhibit an array of yeast and mold strains at clinically meaningful concentrations. 
Future research should elaborate on the clinical significance of this observation by 
expanding our knowledge on the distribution of these bioactive substances on 
healthy and diseased skin.  
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Yeasts Candida albicans ATCC90028 8 8 8 8 32 16 8 16
Candida albicans  CBS 562 0.125 4 4 0.5 32 0.0125 2 16
Candida glabrata CBS 7904 8 8 16 4 32 8 8 8
Candida krusei ATCC6258 8 4 16 4 16 8 4 8
Candida parapsilosis ATCC90018 8 8 8 8 32 16 8 8
Candida tropicalis CBS94 8 4 8 8 8 8 8 16
Candida tropicalis IP 2148-93 0.032 32 32 2 32 0.25 2 8
Cryptococcus albidus CR 127 32 32 32 16 32 32 32 32
Cryptococcus gattii CR86 32 32 16 16 16 32 16 32
Cryptococcus laurentii CR 125 32 32 16 16 32 32 32 32
Cryptococcus neoformans CR192 32 32 16 16 16 32 4 32
Cryptococcus neoformans UOA/HCPF 9235 32 32 32 32 32 32 32 32
Cryptococcus neoformans sero A CR 12 32 32 32 16 32 16 32 8
Cryptococcus neoformans sero AD CR 48 32 32 32 16 32 32 32 8
Cryptococcus neoformans sero AD CR 49 32 32 32 16 32 32 32 16
Cryptococcus neoformans sero C CR 81 32 32 32 16 32 32 32 32
Cryptococcus neoformans sero D CR 96 32 32 32 16 32 32 32 32
Malassezia dermatis CBS9145 16 4 32 4 8 16 4 16
Malassezia furfur CBS 7983 16 8 16 8 16 16 8 16
Malassezia globosa UOA/HCPF 15443 8 2 16 2 2 8 1 8
Malassezia nana CBS9559 16 8 16 8 16 8 16 16
Malassezia pachydermatis CBS1880 16 8 16 8 16 16 8 8
Malassezia restricta UOA/HCPF15428 16 4 4 2 4 8 16 8
Malassezia slooffiae CBS7956 4 2 16 4 8 8 1 4
Malassezia sympodialis  CBS7222 16 16 8 4 32 16 8 16
Malassezia yamatoensis CBS 9725 16 8 16 8 16 16 16 16
Yarrowia lipolytica CBS6124-1 8 8 16 4 16 8 8 8
Molds Aspergillus flavus UOA/HCPF 12726 32 32 32 32 32 32 32 32
Aspergillus flavus UOA/HCPF15587 16 8 8 8 8 16 8 16
Aspergillus fumigatus UOA/HCPF 14662 8 16 32 16 32 4 32 8
Aspergillus fumigatus UOA/HCPF 7431 32 32 32 32 32 32 32 32
Aspergillus fumigatus UOA/HCPF15831 16 32 16 8 8 32 8 16
Aspergillus niger  UOA/HCPF 14744 32 32 32 32 32 32 32 32
Aspergillus niger UOA/HCPF15749 8 4 4 8 8 8 8 4
Exophiala dermatitidis UOA/HCPF 3801 32 32 32 32 32 32 32 32
Exophiala dermatitidis UOA/HCPF3801 16 16 8 16 16 16 16 16
Fusarium solani UOA/HCFP 2213 32 32 16 16 16 32 16 32
Fusarium oxysporum UOA/HCFP 12739 32 32 32 32 32 32 32 32
Rhrizopus oryzae UOA/HCPF 3908 32 32 32 32 32 32 32 32
Rhrizopus oryzae UOA/HCPF15489 8 4 8 4 8 16 8 16  
 
 
Table 1. The fungal species included in the study and the corresponding Minimum Inhibitory Concentrations (MIC) of the 4 Malassezia 
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Table 2. Malassezia associated indole concentration (たg/ml) on skin extracts and respective fungal genera that at least one strain tested would 





  Malassezin ICZ Pityriacitrin Indirubin Species inhibited 
SD1    23.57 Candida,Cryptococcus, 
Malassezia 
 








SD4    1.22 Candida 
SD6 0.06 2.84 1.87  Candida 
PV1  5.97 6.84  Candida, Malassezia 
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Figure 1. Susceptibility of the 33 fungal strains included in the study. Panel A. 
Susceptibility of the fungal genera included in the study against each indole. Panel 
B. Antifungal activity of the tested indoles against all strains of the genera included 
in the study i.e. Malassezia, Candida, Cryptococcus and Aspergillus. Indirubin was 
the most active substance and FICZ the less active one Panel B. Susceptibility of the 
4 genera included in the study against the array of indoles employed. FICZ: formyl-
indolo – [3,2 b] – carbazole; ICZ: indolo- [3,2b] -carbazole. The asterisk denotes 
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